Pharsight
Ask Pharsight
CL BIOSCIENCES LLC PATENTS FACING OPPOSITIONS
Top patents of CL BIOSCIENCES LLC facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3071206B1
17 Feb, 2021
Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of Osteoporosis
Nov, 2034
1